Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2023; 48(4): 926-929


Activated protein C resistance in women using second generation oral contraceptives

Namra Mahmood.




Abstract

Objective: To observe the effect of Combined oral contraceptive pills (COCPs) on activated protein C (APC) resistance after three months of its use and mean change from baseline and was stratified according to age groups and parity.
Methodology: This cross-sectional prospective descriptive study was conducted in Department of Pathology, Post Graduate Medical Institute, Lahore from 1/03/2018 to 02/03/2019. It included 54 female patients aged between 18-45 years who were scheduled by the family planning clinic of Lahore General Hospital, Lahore to start second generation oral contraceptive pills (OCP). Blood samples were collected and activated protein C resistance was assessed before the start of OCP and then after 3 months of onset of contraceptive use.
Results: Mean age of women was 29.5±5.3 years. The parity ranged from 1 to 6 (mean 3.06±1.20). APC resistance increased significantly as seen from a decrease in PCAT/PCAT-0 ratio with a mean change of 0.39±0.23 (p

Key words: Oral Contraceptives, hormonal contraceptives, APC Resistance, Activated Protein C Resistance, Protein C, hypercoagulable state, hypercoagulability, thrombosis, deep vein thrombosis.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.